Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Non-Current Assets (2020 - 2026)

Immuneering's Other Non-Current Assets history spans 7 years, with the latest figure at $278129.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 65.7% to $278129.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $278129.0, a 65.7% decrease, with the full-year FY2025 number at $283562.0, down 78.12% from a year prior.
  • Other Non-Current Assets came in at $278129.0 for Q1 2026, down from $283562.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $1.3 million in Q4 2024, with the low at $89579.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $753538.4 across 5 years, with a median of $743703.0 in 2022.
  • Peak annual rise in Other Non-Current Assets hit 5044.02% in 2022, while the deepest fall reached 90.67% in 2022.
  • Year by year, Other Non-Current Assets stood at $743703.0 in 2022, then skyrocketed by 39.09% to $1.0 million in 2023, then rose by 25.26% to $1.3 million in 2024, then tumbled by 78.12% to $283562.0 in 2025, then dropped by 1.92% to $278129.0 in 2026.
  • Business Quant data shows Other Non-Current Assets for IMRX at $278129.0 in Q1 2026, $283562.0 in Q4 2025, and $631297.0 in Q3 2025.